News & Events / Press Releases
Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
3rd June 2019
Share
Most recent
21st December 2019
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
13th December 2019
See us at NANS 23rd – 26th Jan 2020
16th September 2019
Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
28th June 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
27th June 2019
Saluda Medical Secures Debt Financing From Medtronic